Allpain Injection Solution (Vial) (Nepofen Hydrochloride)

Adult administration

Administer 20 mg of nefopam hydrochloride per dose by intramuscular or intravenous injection. If necessary, repeat every 6 hours, not exceeding 120 mg per day. Administer intravenous injections slowly over at least 15 minutes. After administration, it is preferable to have the patient lie still and rest for 15-20 minutes. When added to an infusion solution such as electrolytes or glucose, administer 30 mg over 4 hours or 40 mg over 6-8 hours, in proportion to the infusion time. It is recommended to avoid mixing this medicine with other medicines for injection. Adjust the dose appropriately according to age and symptoms.

This medication should not be used in patients with epilepsy or myocardial infarction. It should also not be administered to patients taking MAO inhibitors, individuals allergic to this medication or its ingredients, children under 15 years old, patients with a history of seizures, patients with urinary retention due to urethral or prostate issues, and patients with closed-angle glaucoma. Caution is advised when using this medication in elderly patients, pregnant women, and breastfeeding women, as well as in patients taking anticholinergic medications. This medication can cause decreased appetite, nausea, drowsiness, vomiting, excessive sweating, dizziness, increased heart rate, dry mouth, urinary retention, injection site pain, headache, blurred vision, fatigue, nervousness, sleep disturbances, insomnia, agitation, and allergic reactions. These side effects vary with the drug dosage and typically resolve with repeated dosing. When treating inflammation or pain, it is crucial to address the underlying cause, and this medication assists in alleviating symptoms. Use should consider the degree of acute inflammation and pain, and prolonged use of the same medication should be avoided. When used for infectious inflammation, it should be administered with antibiotics or antifungals under careful observation. In elderly patients, the minimal effective dosage should be used with heightened awareness of potential side effects. Patients with impaired liver and kidney function may be affected in the metabolism and excretion of this medication, thus caution is necessary. This medication may cause drowsiness or decreased alertness, so it is advisable not to use it when engaging in activities that require attention, such as driving or operating machinery. The safety of this medication in combination with narcotic analgesics has not yet been established, and when used with acetaminophen-containing drugs, careful monitoring for liver toxicity risk is advised. The use of this medication in conjunction with other non-steroidal anti-inflammatory drugs is not recommended. Caution should be exercised when co-administering with sympathomimetic agents or anticholinergic medications, as side effects may be increased. Use of this medication is not recommended for pregnant or breastfeeding women, and it is not used in children due to the establishment of safety and efficacy not being confirmed. This medication is not recommended for elderly patients due to anticholinergic side effects. In case of overdose, immediate consultation with a physician or pharmacist is required, and monitoring of heart and respiratory status may be necessary. It is advisable to avoid mixing this medication with other drugs for injection. When storing, keep in a sealed container away from children's reach, avoiding direct sunlight, and storing in a cool, dry place.

• loss of appetite
• gastrointestinal disorder
• nausea
• drowsiness
• vomiting
• hyperhidrosis
• dizziness
• tachycardia
• palpitations
• thirst

This medication should be stored in a sealed container to prevent exposure to air, preferably at room temperature between 1 and 30 degrees. Proper storage will maintain the medication's effectiveness and ensure safe usage.

Appearance

A colorless and transparent liquid contained in a colorless and transparent vial.

Package unit

10 vials/box [(2mL/vial × 10)]